Shares of Pfizer Inc. PFE shed 0.75% to $26.42 Monday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index SPX falling 1.07% to 5,906.94 and Dow Jones ...

Fund manager Jonathan Boyar and his team highlighted several stocks that could get a boost thanks to activist shareholders.

Today, Benzinga 's options scanner spotted 9 uncommon options trades for Pfizer. This isn't normal. The overall sentiment of ...

Why Kirk Spano sees Pfizer as one of the next big winners from AI and why he thinks investors should be selling cash secured ...

Highlights,Pfizer increases dividend for the upcoming year to $0.43.,Dividend payout ratio expected to decrease but could ...

Morgan Stanley analyst Terence Flynn notes that BioNTech (BNTX) announced last week that it had reached a settlement agreement with the ...

U.S. stocks looked set to fall in thin trading on Monday, as lingering concerns about elevated interest rates and the ...

I like every part of the phrase "ultra-high-yield dividend stocks." Investing in stocks allows me to own portions of great ...

At the same time, the expiration of key patents is coming up for some major Pfizer drugs, including blood thinner Eliquis and ...

Pfizer Inc. closed $4.92 short of its 52-week high ($31.54), which the company reached on July 30th.

Concurrently, the company has amended its license agreements to provide for a low single-digit percentage royalty on Net Sales of Licensed Products for 2024 onwards. Currently, BioNTech's stock is ...